Clinical trials
Proliferative Vitreoretinopathy clinical trials
Below are recruiting proliferative vitreoretinopathy clinical trials, each written for real people, not researchers. We’re tracking 4 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05523869RecruitingPhase 2
Eye injection medicine after repeat retinal detachment surgery
This Phase 2 trial tests an injection of topotecan into the eye after surgery for retinal detachment that keeps coming back due to scar tissue (proliferative vitreoretinopathy). It may help improve how the retina heals after difficult, repeat operations when vision is usually very guarded.
Toronto, OntarioAges 18 years+ - NCT07682025Enrolling by invitation
Imaging and eye model for PVR study
This study uses eye scans and computer models to better understand and predict a condition called proliferative vitreoretinopathy (PVR), which can cause vision problems after eye surgery. If you already took part in specific studies that collected your eye images, this trial may analyze those images with artificial intelligence (AI).
LondonAges 18 years+ - NCT06033703RecruitingPhase 1/Phase 2
Netarsudil Drops After Retinal Detachment Surgery
This study tests whether netarsudil eye drops can prevent vision-threatening scar tissue (proliferative vitreoretinopathy) after retinal detachment repair. If you are having surgery for a retinal detachment, these drops may reduce the risk of complications.
Boston, MassachusettsAges 18 years+ - NCT06541574RecruitingPhase 2
Preventing scar tissue after retinal detachment surgery
This trial tests if injecting a medication called methotrexate into the eye during retinal detachment surgery can prevent scar tissue from forming. Scar tissue can sometimes cause the retina to detach again, so this treatment might lower that risk.
Cincinnati, OhioAges 18 years+
Hear when a new Proliferative Vitreoretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for proliferative vitreoretinopathy?
- Yes. Clin2 currently lists 4 recruiting proliferative vitreoretinopathy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a proliferative vitreoretinopathy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a proliferative vitreoretinopathy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.